Hashimoto's Thyroiditis: Symptoms, Causes, and How Treatment Works

Hashimoto's thyroiditis (chronic autoimmune thyroiditis) is a condition in which the immune system mistakenly identifies the thyroid's own cells as a threat and gradually destroys them. The main target of the attack is thyroid peroxidase (TPO), an enzyme essential for producing thyroid hormones, against which the body produces TPO antibodies — the most characteristic laboratory marker of this disease.

The destruction of thyroid tissue usually progresses slowly, over years, not suddenly. That's why Hashimoto's often goes unnoticed for a long stretch during which the thyroid — despite the ongoing inflammatory process — still produces enough hormone, before overt hypothyroidism eventually sets in. Hashimoto's is in fact the most common cause of hypothyroidism in countries with adequate iodine intake.

Hashimoto's thyroiditis occurs several to more than ten times more often in women than in men, and its frequency rises with age, though it's also diagnosed in younger adults and children. Overall disease prevalence in the population is estimated at several percent, and a positive TPO antibody titer alone — without overt hypothyroidism — is seen even more often, in over ten percent of healthy, asymptomatic people in some populations.

None of these symptoms is specific to Hashimoto's alone — the exact same symptoms accompany chronic fatigue, depression, nutritional deficiencies, or plain everyday overload. That's one reason hypothyroidism is often diagnosed late — symptoms creep in slowly enough that both the patient and those around them easily attribute them to other, seemingly more obvious causes.

Diagnosis rests on a combination of blood tests, not on symptoms alone. The basic screening test is TSH (thyroid-stimulating hormone) — an elevated level suggests hypothyroidism. With abnormal TSH, free thyroxine (fT4) is checked next, and the autoimmune basis is confirmed with TPO antibody testing (positive in the large majority of patients) and, less often decisively, TG antibodies.

In practice, thyroid ultrasound is sometimes used as a supplementary tool when the clinical picture is unclear — in Hashimoto's the thyroid often has a characteristic, heterogeneous appearance on ultrasound, though imaging alone isn't the basis for diagnosis and doesn't replace hormone and antibody testing.

Hashimoto's rarely starts with overt hypothyroidism right away. The typical course begins with a euthyroid phase with antibodies present (normal hormones, but an ongoing autoimmune process), then subclinical hypothyroidism (elevated TSH with still-normal fT4, often with few or no symptoms), and only over time — in some, but not all, patients — overt hypothyroidism requiring treatment. The pace of this progression varies a great deal between individuals, and not everyone with positive antibodies ends up developing full-blown disease.

The only treatment with proven effectiveness for overt hypothyroidism caused by Hashimoto's is hormone replacement with levothyroxine — a synthetic form of thyroxine (T4) identical to the human hormone. The autoimmune process destroying the thyroid itself currently isn't reversible or curable with medication, so treatment consists of replacing the missing hormone rather than stopping the immune system's attack on the gland.

Hashimoto's has attracted no shortage of promises about elimination diets, detoxes, or supplements supposedly able to "cure" an autoimmune disease. It's worth separating what has real backing in research from what is mostly sold on the strength of patients' fear after a chronic-disease diagnosis.

Ashwagandha is a separate topic — an adaptogen that has attracted a lot of hope in the context of Hashimoto's. We cover this in more depth, with specific studies, in our article on ashwagandha and Hashimoto's thyroid — worth reading if you're specifically interested in that supplement rather than a general overview of the disease.

People with Hashimoto's have an elevated risk of other autoimmune diseases co-occurring — type 1 diabetes, celiac disease, vitiligo, or pernicious anemia — reflecting a shared genetic predisposition to autoimmunity rather than one disease directly causing another. This doesn't mean every patient needs routine screening for all of these, but it's worth keeping in mind with new, unexplained symptoms.

With Hashimoto's, the most to be gained doesn't come from trendy diets or supplements, but from consistent, simple management: regular TSH monitoring, taking levothyroxine as prescribed when indicated, and skepticism toward promises of "curing" an autoimmune disease with a supplement. That's not to say lifestyle doesn't matter — it does, for overall well-being — but it doesn't replace hormonal monitoring or treatment when treatment is genuinely indicated.